The Brain Tumor Epidemiology Consortium is a 503(C) nonprofit organization which aims to support collaborative research and to educate the public on new findings in brain cancer research. Check back to our website for news updates.
The Brain Tumor Epidemiology Consortium (BTEC) is an open scientific forum organized to foster the development of multi-center, international and inter-disciplinary collaborations that will lead to a better understanding of the etiology, outcomes, and prevention of brain tumors. During the process of attaining this mission, BTEC mentors junior investigators or investigators who are new to brain tumor epidemiologic research. Depending on funding, young investigators awards are given during the BTEC annual meetings.
The Consortium was formed in 2003 after an initial meeting sponsored by the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics (DCEG), which is the intramural (in house) research component of the Institute, and the National Institutes of Health's (NIH) Office of Rare Diseases (ORD), and has evolved as a self-directed consortium. BTEC members have formed several Working Groups (WG) developing ideas for coordinated research focusing on adult gliomas, meningiomas, pediatric brain cancers and family-studies.
BTEC holds annual meetings where BTEC Working Groups meet both individually and jointly to discuss current and future collaborations and scientific findings. The lastmeetings were held in 2014, in Vienna, Austria, in 2013 in Chicago, USA and in 2012 in Montpellier France.
BTEC meetings are the only yearly meetings that focus solely on the etiology and epidemiology of brain tumors. These meetings provide an opportunity for international researchers to exchange ideas and form novel collaborations. These forums also provide an opportunity for mentoring young investigators studying these tumors.
BTEC is a National Cancer Institute designated consortium. BTEC is a non-profit 501(c)(3) corporation. BTEC’s mission is only to facilitate collaborative research; we are not a lobbying or advocacy organization.